Skip to main content

Table 4 Fractional contribution of [48V]TiO2-NP absorbed in the GIT to the retention in secondary organs and tissues

From: Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm titanium dioxide nanoparticle aerosols in healthy adult rats after a single two-hour inhalation exposure

 

GIT-absorbed NP fraction after NP gavage [23]

Estimated NP fraction of GIT-absorption cleared from lungs

Ratio: GIT-absorb. NP over measured fractions after NP inhalation

2nd organs

24 h

7d

24 h

7d

24 h

7d

liver

1.27E-04

2.26E-05

1.21E-07

4.62E-08

4.53E-03

5.67E-03

spleen

3.19E-05

1.16E-05

1.68E-09

2.37E-09

2.50E-04

5.65E-04

kidneys

3.82E-05

2.30E-05

2.74E-08

3.19E-08

3.42E-03

3.86E-03

heart

7.96E-05

4.89E-06

2.78E-09

2.24E-10

1.66E-04

1.27E-04

brain

1.01E-05

2.38E-05

7.66E-11

1.12E-09

3.59E-05

1.31E-04

uterus

2.44E-05

4.37E-05

1.43E-09

3.61E-09

2.77E-04

2.29E-04

carcass

8.07E-04

2.88E-04

5.82E-06

4.51E-06

3.42E-02

4.34E-02

skeleton

4.39E-04

8.96E-04

1.87E-06

7.09E-06

2.02E-02

2.20E-02

soft tissue

4.58E-04

5.00E-06

1.40E-06

3.86E-08

1.45E-02

2.15E-02

  1. Mean values of GIT-absorbed fractions after [48V]TiO2-NP gavage in the left two columns at 24 h or 7 days were taken from [23]. Estimated contribution of GIT-absorption of [48V]TiO2-NP cleared from lungs were calculated by multiplying the mean values of [48V]TiO2-NP cleared after 24 h by MCC into the GIT and the sum of all [48V]TiO2-NP which had entered the GIT within the first 7 days p.e. (Table 2) and the fraction in the according left column of the Table 4. These are shown in the middle columns of Table 4. The ratios of GIT-absorbed [48V]TiO2-NP at 24 h or 7 days divided by the mean values of the measured organ or tissue fractions of Table 3 after [48V]TiO2-NP inhalation are presented in the right columns of Table 4. These ratios confirm the rather low contribution of GIT-absorbed [48V]TiO2-NP to the measured accumulation of each secondary organ or tissue in Table 3